Published Date: 08 Mar 2023
Following a major outbreak involving the use of tear drops in 13 US states, experts are offering advice on how to protect dry eyes.
Read Full NewsEurope will need to rethink how it values and pays for innovative medicines or risk losing manufacturing investments and clinical trials, the head of Europe's pharmaceutical industry lobby said.
Patients, doctors, and other healthcare professionals who spoke with KFF Health News say the effort has created confusion, errors, long wait times, and stress.
Research on creatine supplementation has moved from the gym to the brain lab, leading neurologist Heidi Moawad to review the data on creatine’s potential for improving cognitive health.
Patients with MASLD often underreport alcohol use and even modest intake can block improvement. Drs VanWagner and Ajmera share practical tools to quantify intake, spot MetALD, and counsel patients effectively.
MASLD is a silent condition and labs may look normal. Drs VanWagner and Shubrook walk through who to screen, how to use FIB-4, and when primary care can manage MASLD without a specialist.
Palbociclib is now the first CDK4/6 inhibitor approved for metastatic disease regardless of HER2 status.
Mirvetuximab has come up short in the first randomized trial testing an antibody-drug conjugate plus standard carboplatin for patients with platinum-sensitive ovarian cancer.
1.
More nonsmokers are getting lung cancer: Oncologist explains why
2.
Limits to Anti-Nausea Pill Coverage Wear on Cancer Patients and Doctors
3.
Study suggests around 40% of postmenopausal hormone positive breast cancers are linked to excess body fat
4.
New therapeutic strategies raised to prevent and resist metastasis in lymph nodes of breast cancer
5.
Progress in Early Cancer Diagnosis; Breast Cancer in Younger Women; Diet and Cancer.
1.
Beyond the Surface: Understanding the Silent Menace of Abdominal Hematomas
2.
Unlocking the Mysteries of Lymphoblastic Lymphoma: A Journey Into the Unknown
3.
Unlocking Immunity: TILs, Immunotherapy Biomarkers, and Toxicity Management in Oncology
4.
Emerging Therapies and Technologies Reshaping Oncology: Innovations and Impact in 2025
5.
Exploring the Latest Advances in Hodgkin's Lymphoma Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
2.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective
3.
Navigating the Complexities of Ph Negative ALL - Part III
4.
Navigating the Complexities of Ph Negative ALL - Part XII
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation